Robert W. Duggan - 14 Jun 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
14 Jun 2023
Net transactions value
+$11,816,585
Form type
4
Filing time
16 Jun 2023, 16:12:12 UTC
Previous filing
06 Jun 2023
Next filing
07 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Exercise of in-the-money or at-the-money derivative security $11,650,484 +5,683,163 +19% $2.05 36,097,824 14 Jun 2023 Direct
transaction PLSE Common Stock Exercise of in-the-money or at-the-money derivative security $166,101 +81,025 +20% $2.05 492,069 14 Jun 2023 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -5,683,163 -100% $0.000000* 0 14 Jun 2023 Common Stock 5,683,163 $2.05 Direct
transaction PLSE Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -81,025 -100% $0.000000* 0 14 Jun 2023 Common Stock 81,025 $2.05 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.